Sept 7 (Reuters) - Aequus Pharmaceuticals Inc
* Aequus announces positive results for proof of concept clinical trial of anti-nausea patch
* Says formulation was well tolerated with no serious adverse events reported
* Says co owns global rights to program,will look to find a strategic partner to advance towards commercialization in major markets Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.